Ms Tamara Beidle, MSW, LCSW | |
215 S Kirkwood Rd, Ste 202, Kirkwood, MO 63122-4305 | |
(314) 822-5708 | |
Not Available |
Full Name | Ms Tamara Beidle |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 215 S Kirkwood Rd, Kirkwood, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487657557 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW004666 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Tamara Beidle, MSW, LCSW 215 S Kirkwood Rd, Ste 202, Kirkwood, MO 63122-4305 Ph: (314) 822-5708 | Ms Tamara Beidle, MSW, LCSW 215 S Kirkwood Rd, Ste 202, Kirkwood, MO 63122-4305 Ph: (314) 822-5708 |
News Archive
New insights on what causes Alzheimer's disease could arise from a recent discovery made by bioengineers from the University of California, San Diego. The finding concerns the infamous amyloid beta peptides (Aβ)-fragments of which form plaques thought to play a role in Alzheimer's disease.
Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.
Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No. 8,961,947.
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
Researchers of the Cancer Virotherapy Research Group of Bellvitge Biomedicine Research Institute, led by Dr. Ramon Alemany, have developed an oncolytic virus capable of redirecting the patient's immune system against their tumor cells.
› Verified 5 days ago
Alyssa Brussee Patel, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 112 W Jefferson Ave Ste 130, Kirkwood, MO 63122 Phone: 314-223-5456 | |
Mark Beidle, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 215 S Kirkwood Rd, Suite 202, Kirkwood, MO 63122 Phone: 314-822-0650 | |
Mrs. Cathy Ann Williams, MSW,LCSW,CEAP Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122 Phone: 314-989-0643 Fax: 314-989-0712 | |
Joanna Lucia Bissell, LCSW, LCSW-C, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 140 Prospect Ave Ste U, Kirkwood, MO 63122 Phone: 314-690-5873 Fax: 314-677-3326 | |
Rachael Arnold, LCSW, PMH-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12166 Old Big Bend Rd Ste 315, Kirkwood, MO 63122 Phone: 314-274-1102 Fax: 314-279-8201 | |
Britney Beussink, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 343 S Kirkwood Rd, Suite 200, Kirkwood, MO 63122 Phone: 314-570-0093 | |
Lisa Nicole Eilerts, LCSW, RPT, CATP, JD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 134 W Madison Ave, Kirkwood, MO 63122 Phone: 314-403-0079 |